S
Sushruta Koppula
Researcher at Konkuk University
Publications - 101
Citations - 2473
Sushruta Koppula is an academic researcher from Konkuk University. The author has contributed to research in topics: Inflammasome & Oxidative stress. The author has an hindex of 26, co-authored 97 publications receiving 2064 citations. Previous affiliations of Sushruta Koppula include Khon Kaen University & Seoul National University.
Papers
More filters
Journal ArticleDOI
The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism
Hemant Kumar,Hyung-Woo Lim,Sandeep Vasant More,Byung-Wook Kim,Sushruta Koppula,In Su Kim,Dong-Kug Choi +6 more
TL;DR: This work enumerates the common link between aging and PD at the cellular level with special reference to oxidative damage caused by free radicals, and reduces activity of superoxide dismutase, catalase and glutathione with aging might be correlated with the increased incidence of PD.
Journal ArticleDOI
Adaptogenic and nootropic activities of aqueous extract of Vitis vinifera (grape seed): an experimental study in rat model
Satyanarayana Sreemantula,Srinivas Nammi,Srinivas Nammi,Rajabhanu Kolanukonda,Sushruta Koppula,Krishna M. Boini,Krishna M. Boini +6 more
TL;DR: The present study provides scientific support for the antistress (adaptogenic), antioxidant and nootropic activities of V. vinifera seed extract and substantiate the traditional claims for the usage of grape fruits and seeds in stress induced disorders.
Journal ArticleDOI
Inhibitors of microglial neurotoxicity: focus on natural products.
TL;DR: Future works should focus on the discovery of novel drug targets that specifically mediate microglial neurotoxicity rather than neuroprotection, and development of new drugs based on these targets may require a better understanding of microglia biology and neuroinflammation at the molecular, cellular, and systems levels.
Journal ArticleDOI
Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.
TL;DR: Recently developed agents and patents claimed as inhibitors of NADPH oxidase and iNOS enzymes in experimental models of PD are summarized to represent a therapeutic target to reduce neuronal degeneration seen in PD.
Journal ArticleDOI
α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Byung-Wook Kim,Sushruta Koppula,Hemant Kumar,Ju-Young Park,Il-Woung Kim,Sandeep Vasant More,In-Su Kim,Sang-Don Han,Si-Kwan Kim,Sung-Hwa Yoon,Dong-Kug Choi +10 more
TL;DR: Data demonstrate that α-asarone is a promising neuroprotective agent that should be further evaluated and developed for future prevention and treatment of microglia-mediated neuroinflammatory conditions including PD.